Phase I study of selinexor, ixazomib and low-dose dexamethasone in patients with relapsed or refractory multiple myeloma
Meghan Salcedo,Nikoletta Lendvai,Donna Mastey,Julia Schlossman,Malin Hultcrantz,Neha Korde,Sham Mailankody,Alexander Lesokhin,Hani Hassoun,Eric Smith,Urvi Shah,Victoria Diab,Kelly Werner,Heather Landau,Oscar Lahoud,Pamela Drullinsky,Gunjan Shah,David Chung,Michael Scordo,Sergio Giralt,Ola Landgren Clinical Lymphoma Myeloma and Leukemia（2020）
AI 理解论文
溯源树
样例
